Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Calne

Showing results (101-110 of 315) with videos related to

Pageof 32
Sort By:
Neurology|July 1, 1984
Lesions of the putamen and dystonia: CT and magnetic resonance imagingK Burton, K Farrell, D Li, et al.
Neurology|February 1, 1981
Absorption of levodopa after rectal administrationT Eisler, N Eng, C Plotkin, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Progress in the pharmacotherapy of ParkinsonismD B Calne, T Eisler, G Gopinathan, et al.
Parkinsonism & Related Disorders|January 1, 1996
Sympathetic skin response and RR interval variation in manganism and a comparison with Parkinson's diseaseN S Chu, C C Huang, D B Calne
European Neurology|January 1, 1994
Deprenyl and the issue of neuroprotectionF J Vingerhoets, R J Uitti, D B Calne
Neurology|March 1, 1994
Individualizing therapy in patients with disabling Parkinson's disease symptomsD B Calne, R C Duvoisin, W C Koller
British Medical Journal|June 13, 1970
Miosis during L-dopa therapyA S Spiers, D B Calne, P M Fayers
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1972
X-linked scapuloperoneal syndromeP K Thomas, D B Calne, C F Elliott
The Journal of Pharmacy and Pharmacology|February 1, 1976
Altered hypothermic responsivness to (+)-amphetamineD J Amico, D B Calne, H L Klawans
British Medical Journal|June 16, 1973
"On-off" phenomena related to high plasma levodopaL E Claveria, D B Calne, J G Allen
Pageof 32

Showing results (101-110 of 315) with videos related to

Sort By:
Pageof 32
Neurology|July 1, 1984
Lesions of the putamen and dystonia: CT and magnetic resonance imagingK Burton, K Farrell, D Li, et al.
Neurology|February 1, 1981
Absorption of levodopa after rectal administrationT Eisler, N Eng, C Plotkin, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Progress in the pharmacotherapy of ParkinsonismD B Calne, T Eisler, G Gopinathan, et al.
Parkinsonism & Related Disorders|January 1, 1996
Sympathetic skin response and RR interval variation in manganism and a comparison with Parkinson's diseaseN S Chu, C C Huang, D B Calne
European Neurology|January 1, 1994
Deprenyl and the issue of neuroprotectionF J Vingerhoets, R J Uitti, D B Calne
Neurology|March 1, 1994
Individualizing therapy in patients with disabling Parkinson's disease symptomsD B Calne, R C Duvoisin, W C Koller
British Medical Journal|June 13, 1970
Miosis during L-dopa therapyA S Spiers, D B Calne, P M Fayers
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1972
X-linked scapuloperoneal syndromeP K Thomas, D B Calne, C F Elliott
The Journal of Pharmacy and Pharmacology|February 1, 1976
Altered hypothermic responsivness to (+)-amphetamineD J Amico, D B Calne, H L Klawans
British Medical Journal|June 16, 1973
"On-off" phenomena related to high plasma levodopaL E Claveria, D B Calne, J G Allen
Pageof 32